Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives

Immunotherapy has emerged to play a rapidly expanding role in the treatment of cancers. Currently, many clinical trials of therapeutic agents are on ongoing with majority of immune checkpoint inhibitors (ICIs) especially programmed death receptor 1 (PD-1) and its ligand 1 (PD-L1) inhibitors. PD-1 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Yong-Qiang, Gao, Jian, Wang, Shuai, Jiang, Jia-Hao, Deng, Jie, Wang, Hai-Kun, Xu, Bei, Ding, Jian-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099901/
https://www.ncbi.nlm.nih.gov/pubmed/37055838
http://dx.doi.org/10.1186/s12943-023-01772-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099901/
https://www.ncbi.nlm.nih.gov/pubmed/37055838
http://dx.doi.org/10.1186/s12943-023-01772-4

Ejemplares similares